Next Generation Sequencing Market, By Product Type (Instruments, Reagents & Consumables), By Sequencing Type (Whole Genome Sequencing, Whole Exome Sequencing, RNA Sequencing, Targeted Re-sequencing, Others), By Application (Drug Discovery, Personalized Medicine, Genetic Screening, Diagnostics, Others), By End User (Hospitals & Clinics, Academic & Research Institutes, Biopharmaceutical Companies, Clinical Laboratories, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
On January 30, 2024, QIAGEN Digital Insights (QDI), the bioinformatics division of QIAGEN, a provider of sample and assay technologies, announced that the improved QIAGEN CLC Genomics Workbench Premium with LightSpeed technology now supports next-generation sequencing (NGS) for somatic cancer secondary analysis. The software accelerator transforms raw sequencing data in FASTQ files into interpretable lists of genetic variants in VCF files at an unparalleled low cost and speed.
On January 18, 2024, Quantum-Si Incorporated, a protein sequencing company, stated that it had signed an agreement with a new distributor to make the company's protein sequencing device, Platinum, available for the first time in Japan. TOMY Digital Biology Co., Ltd., a well-known importer and distributor, will distribute Quantum-Si's next-generation protein sequencer and related consumables across Japan.
On January 09, 2024, Ultima Genomics, the developer of a revolutionary new ultra-high throughput sequencing architecture, and Quest Diagnostics, a leading provider of diagnostic information services, have announced a collaboration to use Ultima's next generation sequencing (NGS) technology in oncology and other clinical areas.
In November 2023, QIAGEN and Element Biosciences, Inc., a life science company, announced a strategic partnership to provide full next-generation sequencing (NGS) workflows for the AVITI System, an innovative sequencing platform built on Element's revolutionary Avidity sequencing chemistry.